Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lacosamide Replacement in Japanese Adults with Partial-onset Seizures
NCT02192814Phase 3Completed
- Sponsor
- UCB
- Start
- Jun 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in focal onset seizure, sponsored by UCB. Primary endpoints: The Total Number of Subjects Experiencing at Least One Adverse Event During the Study and The Total Number of Subject Withdrawal Due to Adverse Events During the Study. Started Jun 2014; status: completed.
02
Drugs
lacosamide
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT02192814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192814.